當前位置:
首頁 > 最新 > 美國FDA說葯之HPV疫苗

美國FDA說葯之HPV疫苗

2017年,生物製品界的網紅,非HPV疫苗莫屬。

你是不是想打,又害怕,不打,更害怕?

寶寶用藥,安全第一

安全用藥,請看漫醫

疫苗這件事吧,你說我說,大家都在說,眾說紛紜,你談我談,所有人在談,談天說地。

不班門弄斧,有請美國FDA,螞蟻粉們,搬個小凳子,拿個小本子,開講啦!

美國FDA說

HPV (human papillomavirus)

HPV(人乳頭瘤病毒)

HPV (human papillomavirus) is a sexuallytransmitted virus. It is passed on through genital contact (such as vaginal andanal sex). It is also passed on by skin-to-skin contact. HPV is not a newvirus. But many people don"t know about it. Most people don"t have anysigns. HPV may go away on its own-- without causing any health problems.

HPV(人乳頭瘤病毒)是一種通過性傳播的病毒,通過生殖器接觸(例如陰道性交和肛交)進行傳播,還能通過皮膚接觸進行傳播。HPV不是一種新病毒,但許多人並不了解它,大多數人也並沒有出現任何徵兆。HPV能夠自行消失,而不引起任何健康問題。

Who can get HPV?

哪類人會感染上HPV?

Anyone who has ever had genital contactwith another person may have HPV. Both men and women may get it -- and pass iton-- without knowing it. Since there might not be any signs, a person may haveHPV even if years have passed since he or she had sex.

任何與其他人有過生殖器接觸的人群都有可能感染HPV。男性和女性都有可能感染HPV,並在毫不知情的情況下進行傳播。由於事先可能沒有任何徵兆,所以即使發生性行為幾年後,還是有可能感染上HPV。

You are more likely to get HPV if you have:

若出現以下情況,則您感染HPV的可能性更大:

sex at an early age,

過早發生性行為

many sex partners, or

性伴侶較多,或

a sex partner who has had many partners.

其中一方擁有多個性伴侶

If there are no signs, why do I need toworry about HPV?

如果沒有任何徵兆,我為何需要擔憂HPV?

There are over 100 different kinds of HPVand not all of them cause health problems. Some kinds of HPV may cause problemslike genital warts. Some kinds of HPV can also cause cancer of the cervix,vagina, vulva, or anus. Most of these problems are caused by types 6, 11, 16 or18.

HPV具有100多種不同的類型,但並非所有的類型都能夠引起健康問題。某些類型的HPV病毒會引起生殖器疣,而某些類型的HPV病毒則會引起子宮癌、陰道癌、外陰癌和肛門癌。絕大多數此類問題都是由6型、11型、16型或18型HPV病毒引起。

註:譯文不當之處,懇指正。

目前,美國上市的HPV疫苗共有三種,具體如下:

美國FDA說

Human Papillomavirus Quadrivalent (Types 6,11, 16, 18) Vaccine, Recombinant

四價重組HPV疫苗(針對6型、11型、16型和18型四種病毒)

Gardasil

加德西

STN: 125126

生物製品許可證申請號:125126

Proper Name: Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18)Vaccine, Recombinant

專有名詞:四價重組HPV疫苗(針對6型、11型、16型和18型四種病毒)

Tradename: Gardasil

商標名:加德西

Manufacturer: Merck & Co., Inc

生產廠家:默沙東

Indications:

用藥指南:

Prevention of vulvar and vaginal cancer

預防陰道癌和宮頸癌

Vaccination in females 9 through 26 years of age for prevention ofthe following diseases caused by Human Papillomavirus (HPV) Types 6, 11, 16,and 18:

針對9-26歲女性接種,用於預防6型、11型、16型和18型四種HPV病毒引起 的下述疾病:

Cervical cancer

宮頸癌

Genital warts (condyloma acuminata) and the following precancerousor dysplastic lesions:

生殖器疣(尖銳濕疣)以及下述癌前病變:

Cervical adenocarcinoma in situ (AIS)

宮頸原位腺癌(AIS)

Cervical intraepithelial neoplasia (CIN) grade 2 and grade 3

子宮頸上皮不典型增生(CIN)II級和III級

Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3

外陰上皮內瘤變(VIN)II級和III級

Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3

陰道上皮內瘤變(VaIN)II級和III級

Cervical intraepithelial neoplasia (CIN) grade 1

子宮頸上皮不典型增生(CIN)I級

Vaccination in boys and men 9 through 26 years of age for theprevention of genital warts caused by HPV types 6 and 11

針對9-26歲男性接種,用於預防6型和11型兩種HPV病毒引起的生殖器疣

Vaccination in people ages 9 through 26 years for the prevention ofanal cancer and associated precancerous lesions due to human papillomavirus(HPV) types 6, 11, 16, and 18

針對9-26歲的人群接種,用於預防6型、11型、16型和18型四種HPV病毒引起的肛門癌及相關癌前病變

Human Papillomavirus Bivalent (Types 16 and18) Vaccine, Recombinant

二價重組HPV疫苗(針對16型和18型兩種病毒)

Cervarix

希瑞適

STN:BL 125259

生物製品許可證申請號:125259

Proper Name:Human Papillomavirus Bivalent (Types 16 and 18) Vaccine,Recombinant

專有名詞:二價重組HPV疫苗(針對16型和18型兩種病毒)

Tradename: Cervarix

商標名:希瑞適

Manufacturer: GlaxoSmithKline Biologicals

生產廠家:葛蘭素史克

Indications:

用藥指南:

Prevention of cervical cancer, cervical intraepithelial neoplasia(CIN) grade 2 or worse and adenocarcinoma in situ, and cervical intraepithelialneoplasia (CIN) grade 1, caused by oncogenic human papillomavirus (HPV) types16 and 18, in females 9 through 25 years of age

針對9-25歲女性接種,用於預防16型和18型兩種HPV病毒引起的子宮頸上皮不典型增生(CIN)II級或更高級、宮頸原位腺癌(AIS)以及子宮頸上皮不典型增生(CIN)I級

Human Papillomavirus 9-valent Vaccine,Recombinant

九價重組HPV疫苗

Gardasil 9

加德西9

STN: 125508

生物製品許可證申請號:125508

Proper Name: Human Papillomavirus 9-valent Vaccine, Recombinant

專有名詞:九價重組HPV疫苗

Tradename: Gardasil 9

商標名:加德西9

Manufacturer: Merck & CO., Inc.

生產廠家:默沙東

Indications:

用藥指南:

Indicated in girls and women 9 through 26years of age for the prevention of the following diseases:

針對9-26歲女性接種,用於預防下述疾病:

Cervical, vulvar, vaginal, and anal cancer caused by HumanPapillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58. (1.1)

16型、18型、31型、33型、45型、52型和58型七種HPV病毒引起的宮頸癌、外陰癌、陰道癌和肛門癌。(1.1)

Genital warts (condyloma acuminata) caused by HPV types 6 and 11.(1.1)

6型和11型兩種HPV病毒引起的生殖器疣(尖銳濕疣)(1.1)

And the following precancerous ordysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58:

以及6型、11型、16型、18型、31型、33型、45型、52型和58型九種HPV病毒引起的癌前病變:

Cervical intraepithelial neoplasia (CIN) grade 2/3 and cervicaladenocarcinoma in situ (AIS). (1.1)

子宮頸上皮不典型增生(CIN)II/III級以及宮頸原位腺癌(AIS)

Cervical intraepithelial neoplasia (CIN) grade 1. (1.1)

子宮頸上皮不典型增生(CIN)I級(1.1)

Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3. (1.1)

外陰上皮內瘤變(VIN)II級和III級(1.1)

Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3. (1.1)

陰道上皮內瘤變(VaIN)II級和III級

Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3. (1.1)

肛門上皮內瘤變(AIN)I級、II級和III級(1.1)

GARDASIL 9 is indicated in boys andmen 9 through 26 years of age for the prevention of the following diseases:

加德西9針對9-26歲男性接種,用於預防下述疾病:

Anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, and 58.(1.2)

16型、18型、31型、33型、45型、52型和58型七種HPV病毒引起的肛門癌。(1.2)

Genital warts (condyloma acuminata) caused by HPV types 6 and 11.(1.2)

6型和11型兩種HPV病毒引起的生殖器疣(尖銳濕疣)(1.2)

And the following precancerous ordysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58:

以及6型、11型、16型、18型、31型、33型、45型、52型和58型九種HPV病毒引起的下述癌前病變:

Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3. (1.2)

肛門上皮內瘤變(AIN)I級、II級和III級(1.2)

註:譯文不當之處,懇請指正。

https://www.fda.gov/forconsumers/byaudience/forwomen/ucm118530.htm

HPV

關注健康,關注自身,病毒走開,幸福自來。

關注漫醫,關注我們,安全用藥,科學用藥。

安全用藥,從關注成分開始。

科學用藥,從關注劑量開始。

公眾號:manhuayiyao

文字:小叨

編譯:大白

ID: manhuayiyao

漫畫醫藥事兒

漫醫,分享醫藥那些事兒。

小叨君,中國藥科大學藥物製劑專業畢業,曾在藥廠做過生產、驗證以及檢驗,現在藥店小藥師一枚,愛生活,愛科普,愛分享。

大白,無業游民,專業打雜一百年。

我們是漫醫,我們在努力,我們在等你。


喜歡這篇文章嗎?立刻分享出去讓更多人知道吧!

本站內容充實豐富,博大精深,小編精選每日熱門資訊,隨時更新,點擊「搶先收到最新資訊」瀏覽吧!


請您繼續閱讀更多來自 漫畫醫藥事兒 的精彩文章:

TAG:漫畫醫藥事兒 |